Identification of plumericin as a potent new inhibitor of the <scp>NF</scp>‐<scp>κB</scp> pathway with anti‐inflammatory activity <i>in vitro</i> and <i>in vivo</i>

Abstract

Plumericin is a potent inhibitor of NF-κB pathways with a new chemical scaffold. It could be further explored as a novel anti-inflammatory lead compound.